LearnGlossaryMarketStocksSuperinvestorsSign in

ESTA

Establishment Labs Holdings Inc.

Healthcare · $1.9B market cap

Verdict

We can't put a fair value on ESTA right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-13.7% a year✗
Sales growth25.3% a year✓
Free cash flow growth—?
Return on invested capital-20.1%✗

Follow ESTA

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds ESTA. In Q1 2026, 1 added. Who we track

Polen Capital Management

Polen Capital Management · as of Q2 2026

$1.9M

22,541 shares

Moves in Q1 2026

Added: Polen Capital Management

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works